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Windows file sharing Server Message Block protocol was 
developed to integrate with OSSEC, allowing client free FIM 
for Windows systems.  
OSSEC was installed onto an in-house virtualised server and 
configured to perform nightly checks on a non-clinical test 
infrastructure, monitoring both workstations and file servers 
with read-only permissions. The resulting checksums were 
independently verified. Subsequent file changes are recorded 
in a robust database management system (PostgreSQL) for 
audit, with alerts sent via the hospital email to provide a 
convenient method of informing the TPS team of events.  
Results: OSSEC calculated MD5 and SHA1 checksums for of all 
files specified for inclusion. Alterations to files subsequently 
were notified to the designated email addresses. The 
program did not cause any change to the system being 
monitored. Following successful testing, OSSEC has been in 
routine use for 12 months and has sent nearly 1400 change 
notifications. 99.8% of these were either planned changes to 
configuration files, alterations to user preferences or updates 
to log files, used to test OSSEC functionality. A single 
unplanned change to critical beam data was detected. In this 
case, the change caused the TPS to cease functioning. OSSEC 
provided a list of alterations, which could be used to revert 
the system to an operational state. 
Conclusions: OSSEC can be implemented in a multi-vendor, 
multi-platform radiotherapy department to perform FIM, in 
an integrated and unified manner. Monitoring the integrity of 
executable files and the data sets on which they depend on, 
provides a robust method of assuring software remains in the 
same state as it was commissioned, with a minimum amount 
of human intervention. 
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Purpose/Objective: Volumetric modulated arc therapy 
(VMAT) is one of the methods of delivering stereotactic body 
radiation therapy (SBRT) for lung tumors. VMAT allows fast 
delivery. Nevertheless is thought to increase the lung volume 
dose, especially in low dose area. Therefore we assessed the 
lung volume receiving 5 and 20 Gy delivered with VMAT plans 
and also dose for contralateral lung. 
Materials and Methods: We collected 49 VMAT- SBRT plans 
introduced for patients with lung tumors. Of the patients, 7 
were female, 42 were male. Three patients had two 
ipsilateral lung tumors. Three patients undergone 
pulmonectomy. Based on 4D CT there were outlined 
structures: GTV, ITV, PTV (ITV+5mm) and organs at risk.  
Every plan was created with two partial arcs, in order to 
decrease dose to contralateral lung. Lung volume receiving 5 
and 20 and separately V5 for contralateral were assessed. No 
GTV subtraction from lung volume were used. According to 
RTOG SBRT trials dose constrains were V5-50%, V20-20%. 
Results: Mean GTV volume was 17,6 cm3 (range 0,8-89 cm3 , 
median 11,6 cm3 ), ITV 26,9 cm3 (range 09-159,2 cm3 , median 
20,2 cm3), PTV 65,9 cm3 (range 6,5-274 cm3 , median 48,3 
cm3). The mean volume of lung receiving more than 20 Gy 
was 7,2% (range 1,1-22,8% , median 6,1%) and more than 5 Gy 
was 19,2% (range 4,3-47,1% , median 18,6%). The mean 
contralateral lung V5 was 4,5% (range 0-26,2% , median 1,6%). 
Beside one patient lung dose constrains were easily archived 
and the dose to contralateral lung was highly limited. 
Conclusions: Two partial arcs VMAT for SBRT for lung tumors 
allow creating save plan in addition of lung tissue. Even in 
low dose area the VMAT plan is acceptable. This method also 
protect contralateral lung. 
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Purpose/Objective: Thoracic re-irradiation is commonly 
found in clinical practice as a considerable number of 
patients with primary or metastatic lung lesions require 
repeat treatments to the thorax. Stereotactic body radiation 
therapy (SBRT) is an efficient modality for repeat treatments 
because it allows for delivery of high radiation dose to the 
target while minimizing the dose to the surrounding tissue. 
This case study regards a 75-year-old male patient, known for 
right lung cancer in complete remission, treated in 2011 with 
60 Gy (30x2 Gy) including mediastinum. In 2013 the patient is 
treated for pleural relapse on the right side with 48 Gy (8x6 
Gy). One year later in 2014, the patient needed treatment 
for a left lung cancer with 30 Gy (5x6 Gy). How to plan and 
evaluate the re-irradiation in this clinical situation? Which 
OAR will be the clinical limit? 
Materials and Methods: For SBRT planning (2014), the PTV 
was defined in a free breathing CT simulation, based on ITV 
(internal target volume) strategy. SBRT treatment plans were 
generated in Tomotherapy treatment planning system (VoLo, 
Accuray) to deliver the prescribed dose to the PTV of 30 Gy 
in 5 fractions. To estimate composite mean/max dose we 
used Velocity AI software, the SBRT dose was converted to 2 
Gy equivalent using the linear-quadratic model (EQD2) tool, 
(α/β = 3 Gy) for lung, heart, esophagus and bronchus, (α/β = 
2 Gy) for the spinal cord and (α/β = 10 Gy) for the PTV. For 
the plan comparison, dosimetric parameters for the analyze 
included PTV coverage, mean dose to ipsilateral lung, mean 
dose to both lungs, volume receiving 20 Gy (V20) of both 
lungs, max dose for esophagus, max dose for spinal cord, max 
dose for bronchus and max dose to the heart.  
Results: In a first analysis, we estimate the esophagus max 
dose in EQD2 of 82.21 Gy on the first composite plan, non 
acceptable in clinical practice. We then re-planned using a 
PRV (planning risk volume) for esophagus and re-optimized. 
The PTV D95% for the first plan is 28.5 Gy vs 29 Gy on the 
second plan. When we compare the first and second 
composite plans EQD2, we obtained a mean dose to both 
lungs of 10.57 Gy vs. 10.97 Gy; V20 Gy of 14% vs. 14.8%; 
esophagus max of 64.8 Gy vs. 82.21 Gy, spinal cord max dose 
of 30.79 Gy vs. 29.41 Gy; bronchus max dose of 81.12 Gy vs. 
94.13 Gy and for heart max dose of 44.04 Gy vs. 48.72 Gy. 
Conclusions: This case underline the new information 
obtained from tools such as image registration and scaled 
dose volume using biological equivalent transformation. The 
technique allowed us to understand easier which OAR will be 
